Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease

Related articles

1. Associations between fluid biomarkers and PET imaging ([ ¹¹ C]UCB-J) of synaptic pathology in Alzheimer’s disease

   This article has 11 authors:

   1. Johanna Nilsson
   2. Adam P. Mecca
   3. Nicholas J. Ashton
   4. Elaheh Salardini
   5. Ryan S. O’Dell
   6. Richard E. Carson
   7. Andrea L. Benedet
   8. Kaj Blennow
   9. Henrik Zetterberg
   10. Christopher H. van Dyck
   11. Ann Brinkmalm

2. Alpha-Synuclein co-pathology in Alzheimer’s Disease drives tau accumulation

   This article has 16 authors:

   1. Felix L. Struebing
   2. Xiaoxuan Song
   3. Teodoro De Vecchi
   4. Jeannine Widmann
   5. Federico Fierli
   6. Viktoria Ruf
   7. Qilin Tang
   8. Thomas Arzberger
   9. Sigrun Roeber
   10. Thomas Koeglsperger
   11. Otto Windl
   12. Amir Dehsarvi
   13. Matthias Brendel
   14. Nicolai Franzmeier
   15. Juliane Winkelmann
   16. Jochen Herms

3. Evidence for cPLA2 activation in Alzheimer’s Disease Synaptic Pathology

   This article has 22 authors:

   1. Qiu-Lan Ma
   2. Brandon Ebright
   3. Boyang Li
   4. Jing Li
   5. Jasmin Galvan
   6. Ashley Sanchez
   7. Michael Renteln
   8. Dante Dikeman
   9. Shaowei Wang
   10. Bilal E. Kerman
   11. Paul Seidler
   12. Berenice Gutierrez-Grebenkova
   13. Brooke E. Hjelm
   14. Debra Hawes
   15. Anne E. Hiniker
   16. Kyle M. Hurth
   17. David A. Bennett
   18. Stan G. Louie
   19. Helena C. Chui
   20. Agenor Limon
   21. Zoe Arvanitakis
   22. Hussein N. Yassine